Quantum sensors for magnetic measurements - 02/06/2026 New insights into muscle physiology – contactless and three-dimensional Contactless measurement of muscle activity and training effects: using highly sensitive quantum sensors, researchers at the Universities of Tübingen and Stuttgart are setting new standards. This technology has the potential to revolutionise clinical diagnostics and optimise training and neuroscience research.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-insights-muscle-physiology-contactless-and-three-dimensional
Press release - 01/06/2026 Central Institute of Mental Health joins international Lancet Commission on schizophrenia Leading scientists are pooling their expertise to further advance research and care for psychotic disorders and to align them more closely with the needs of affected individuals. https://www.gesundheitsindustrie-bw.de/en/article/press-release/central-institute-mental-health-joins-international-lancet-commission-schizophrenia
Press release - 29/05/2026 FCI Supports Teaching Concept for the Chemistry of Tomorrow The German Chemical Industry Fund (FCI) is supporting the course offering ‘DigiChemJN’ at the Faculty of Chemistry and Pharmacy. DigiChemJN strengthens students’ data literacy by providing them qualifications in data-based research methods, experimental datasets, and artificial intelligence (AI).https://www.gesundheitsindustrie-bw.de/en/article/press-release/fci-supports-teaching-concept-chemistry-tomorrow
Press release - 28/05/2026 An immune defence guide Which cellular processes ensure that immune responses are controlled precisely? A new study by the Institute of Cell Biology and Immunology Thurgau (BITG) and the University of Konstanz decodes a decisive signalling pathway.https://www.gesundheitsindustrie-bw.de/en/article/press-release/immune-defence-guide
Press release - 27/05/2026 New Emmy Noether Junior Research group investigates the mode of action of Antimetabolite Chemotherapy How do antimetabolite cancer drugs damage the genetic material of malignantly transformed cells and thereby destroy them? How might these drugs be used more precisely, particularly in the treatment of pediatric tumors? A new research group led by Dr. Christopher Carnie, a scientist at the Heidelberg Faculty of Medicine at Heidelberg University, will address these questions. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-emmy-noether-junior-research-group-investigates-mode-action-antimetabolite-chemotherapy
Press release - 27/05/2026 Funding for three Collaborative Research Centres at DZHK sites The German Research Foundation (DFG) is establishing new Collaborative Research Centres and extending existing research networks. Several DZHK sites are also involved. Particular emphasis is being placed on new research approaches to inflammation and thrombosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/Funding-for-three-Collaborative-Research-Centres-at-DZHK-sites
Press release - 26/05/2026 Heidelberg based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide) Joint press release of the Heidelberg Faculty of Medicine at Heidelberg University and the German Center for Infection Research: With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the German Center for Infection Research (DZIF) has now reached the world’s most important pharmaceutical market.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-based-development-revolutionizes-hepatitis-d-therapy-worldwide-us-food-and-drug-administration-fda-approves-hepatitis
Press release - 26/05/2026 How blood stem cells diversify Different types of bone marrow stem cells give rise to blood and immune cells. A team led by Simon Haas now reports in “Nature Cell Biology” how that diversity develops. The findings could help improve stem cell therapies, including treatments for blood cancers.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-blood-stem-cells-diversify
Press release - 21/05/2026 Breakthrough in synthetic cell research Living systems such as cells rely on membrane pores and channels to transport molecules, exchange signals, and organize biochemical reactions. These functions emerge from dynamic interactions between molecular components. Researchers at the University of Stuttgart have used DNA nanotechnology to develop a synthetic membrane architecture that mimics such interactions. https://www.gesundheitsindustrie-bw.de/en/article/press-release/breakthrough-synthetic-cell-research
Press release - 21/05/2026 Sartorius opens new competence center for cell and gene therapy components in Freiburg, Germany The life science group Sartorius has opened a new center in Freiburg, Germany, dedicated to the development and production of quality-critical materials for the cell and gene therapy market. In Freiburg, the company manufactures essential components such as cytokines and growth factors used in these novel therapies. With an investment of more than 140 million euros, Sartorius is reaffirming its strategic focus on this emerging business area.https://www.gesundheitsindustrie-bw.de/en/article/press-release/sartorius-opens-new-competence-center-cell-and-gene-therapy-components-freiburg-germany
Press release - 21/05/2026 Why pain persists long after injuries have healed Chronic pain is among the most common and burdensome health conditions worldwide. But which processes in the nervous system cause pain to be “learned” and thus persist long term? And how can insights into the mechanisms underlying chronic pain be translated into new therapeutic approaches? These questions have been at the core of Rohini Kuner’s research for many years.https://www.gesundheitsindustrie-bw.de/en/article/press-release/why-pain-persists-long-after-injuries-have-healed
Event - 17/09/2026 - 18/09/2026 Translational Protein Biomarker Workshop Reutlingen, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/translational-protein-biomarker-workshop
Funding Continuous Hormone Monitoring Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 26/06/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/continuous-hormone-monitoring
Funding Funke Quantum-Driven Intelligence Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantum-driven-intelligence
Funding Funke QuantumSense Exploration Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantumsense-exploration
Cancer prevention with a single jab - 20/05/2026 Therapeutic vaccine against HPV-induced tumours Persistent infections with human papillomaviruses (HPV) are the primary cause of cervical cancer. Researchers from Heidelberg have developed a promising therapeutic vaccine consisting of immunogenic virus peptides linked to silica nanoparticles, which is currently being investigated in preclinical studies. The vaccine activates specific cytotoxic T cells and is usable regardless of HLA type.https://www.gesundheitsindustrie-bw.de/en/article/news/therapeutic-vaccine-against-hpv-induced-tumours
Press release - 18/05/2026 Unlocking the Lung’s Ability to Heal: NK Cell Immunotherapy offers New Hope for Fibrosis Research jointly led by scientists at the Heidelberg site of the German Center for Lung Research and investigators in Boston at Massachusetts General Hospital and Harvard Medical School identifies a new immunotherapy-based approach for lung fibrosis: reactivating natural killer cell (NK cells) to eliminate senescent fibroblasts, reverse scarring and restore the lung’s ability to heal.https://www.gesundheitsindustrie-bw.de/en/article/press-release/unlocking-lungs-ability-heal-nk-cell-immunotherapy-offers-new-hope-fibrosis
Press release - 18/05/2026 Gene scissors show promise for treating a rare immune disorder Medical Center – University of Freiburg demonstrates a fundamental therapeutic approach for hereditary immune system defects in a mouse model. The safety profile of genome editing varies significantly depending on the method and cell type.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-scissors-show-promise-treating-rare-immune-disorder
Press release - 15/05/2026 Heidelberg Collaborative Research Centre “Molecular Circuits of Heart Disease” secures second funding period The Collaborative Research Centre (CRC) 1550 “Molecular Circuits of Heart Disease” at Heidelberg University is entering its second funding period. The German Research Foundation (DFG) has approved approximately EUR 17.4 million in funding for the next four years. The spokesperson is Johannes Backs, Professor of Experimental Cardiology at the Heidelberg Faculty of Medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-collaborative-research-centre-molecular-circuits-heart-disease-secures-second-funding-period
Press release - 15/05/2026 Neuroendocrine Tumors: Freiburg Becomes a European Center of Excellence The Medical Center – University of Freiburg has been certified for the first time as a “Center of Excellence” by the European Neuroendocrine Tumor Society (ENETS). The professional association recognizes specialized centers that treat rare tumor diseases in accordance with established quality standards. Neuroendocrine tumors are rare cancers that can arise from hormone-producing cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/neuroendocrine-tumors-freiburg-becomes-european-center-excellence
Press release - 13/05/2026 “AI doesn't really have a clue what it's doing” AI is transforming science and does not stop at neuroscience. In this interview, we speak to Gabriele Lohmann about her research at the intersection of the brain and algorithms. She talks about the use of artificial intelligence as a research tool, the decoding of brain activity, and why large language models do not understand what they are doing.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-doesnt-really-have-clue-what-its-doing
Press release - 13/05/2026 NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies NVision announced a $55 million Series B led by Abbott and unveiled PIQC, a new quantum computing platform built on its molecular quantum technology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nvision-expands-quantum-sensing-quantum-computing-accelerate-discovery-and-validation-new-therapies-en
Funding GRIOS call for evidence synthesis 2026 Funding programme, Funded by: European Science Foundation (ESF), sb_search.searchresult.label.programSubmissionDate: 20/07/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/grios-call-evidence-synthesis-2026
Press release - 12/05/2026 3D Microscopy: Laser Rotates Samples Contact-Free Until now, it has been technically nearly impossible to rotate highly sensitive samples in all directions under a microscope without making contact. Researchers at the KIT have developed a new laser-based technique that allows microscopic samples such as cells to be rotated contact-free in all three spatial directions. The laser creates tiny temperature differences in the liquid, which trigger gentle fluid flows that move the sample. https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-microscopy-laser-rotates-samples-contact-free
Press release - 12/05/2026 The Silent Killer: Early Detection and Targeted Treatment of High Blood Pressure High blood pressure is one of the most common causes of heart attacks, strokes, kidney damage, and vascular diseases. Many people affected experience no symptoms for a long time. This is precisely why it is important to check your blood pressure regularly. To mark World Hypertension Day on May 17, the Medical Center – University of Freiburg is providing information on warning signs, diagnosis, and treatment options.https://www.gesundheitsindustrie-bw.de/en/article/press-release/silent-killer-early-detection-and-targeted-treatment-high-blood-pressure